Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of H5N1 Influenza Vaccine in Adults and Elderly
NCT00415129Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Primary completion
- Dec 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of A/H5N1 inactivated, split-virion influenza virus in Influenza A H5N1 infection (H5N1), sponsored by Sanofi. Started Jun 2006; status: completed.
02
Drugs
A/H5N1 inactivated, split-virion influenza virus
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00415129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415129.